ArticleKidney medicine2025
Trends of Biopsy-Proven Kidney Diseases in Romania: A Single-Center Registry Report Spanning 28 Years.
Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Landscape of kidney biopsy diagnoses in a Romanian pediatric cohort.BMC nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: The epidemiologic landscape of biopsy-proven kidney diseases in Romania and its evolution over time are poorly understood. Study Design: Register-based single-center retrospective study. Setting & Participants: Adult native kidney biopsy records between 1996 and 2023 from the registry of the Victor Babeş National Institute of Pathology, Bucharest, Romania. Predictor: Year of biopsy. Outcomes: Histopathological diagnosis. Analytical Approach: Temporal trends in participant demographics and frequency of histopathological diagnoses were evaluated using regression analyses. Results: We identified a total of 1,937 adult native kidney biopsy records. The median age at diagnosis was 46 years (IQR, 33-58 years), and men represented 54.5% of participants. Immunoglobulin A nephropathy was the most common diagnosis (15.4%), followed by membranous nephropathy (12.5%), focal segmental glomerulosclerosis (8.3%), minimal change disease (8.2%), lupus nephritis (7.0%), and diabetic nephropathy (6.9%). Our results indicate a change in demographic composition of the population biopsied, reflected in an increase in the median age at biopsy over time, and a decrease in the male proportion in recent periods. We identified historically increasing immunoglobulin A nephropathy and diabetic nephropathy frequencies, and decreasing membranous nephropathy and minimal change disease frequencies, which stabilized over more recent periods. In contrast, lupus nephritis registered an increasing trend that was maintained in recent times. Limitations: This is a single-center study and does not report on the clinical data of the participants. Conclusions: Our findings, corroborated with those of other centers in Romania, suggest that kidney disease trends in the Romanian population largely align with those reported in other European registries. However, we echo concerns voiced in other biopsy registry studies, regarding the challenges encountered in attempting direct comparisons between published reports within and across countries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.